Voloridge Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.8M | Buy |
854,634
+477,430
| +127% | +$18.9M | 0.12% | 209 |
|
|
2025
Q1 | $11.4M | Buy |
377,204
+60,261
| +19% | +$1.82M | 0.04% | 527 |
|
|
2024
Q4 | $11.1M | Sell |
316,943
-63,698
| -17% | -$2.23M | 0.04% | 541 |
|
|
2024
Q3 | $15.2M | Buy |
+380,641
| New | +$15.2M | 0.06% | 452 |
|
|
2024
Q2 | – | Sell |
-191,367
| Closed | -$8.3M | – | 1289 |
|
|
2024
Q1 | $8.3M | Sell |
191,367
-72,754
| -28% | -$3.15M | 0.03% | 530 |
|
|
2023
Q4 | $13.4M | Buy |
+264,121
| New | +$13.4M | 0.05% | 407 |
|
|
2023
Q3 | – | Sell |
-5,348
| Closed | -$219K | – | 1494 |
|
|
2023
Q2 | $219K | Buy |
+5,348
| New | +$219K | ﹤0.01% | 1312 |
|
|
2023
Q1 | – | Sell |
-30,709
| Closed | -$1.16M | – | 1472 |
|
|
2022
Q4 | $1.16M | Buy |
+30,709
| New | +$1.16M | 0.01% | 1105 |
|
|
2022
Q2 | – | Sell |
-189,556
| Closed | -$7.02M | – | 1535 |
|
|
2022
Q1 | $7.02M | Sell |
189,556
-77,289
| -29% | -$2.86M | 0.04% | 518 |
|
|
2021
Q4 | $8.12M | Buy |
+266,845
| New | +$8.12M | 0.04% | 530 |
|
|
2020
Q4 | – | Sell |
-94,905
| Closed | -$4.5M | – | 1441 |
|
|
2020
Q3 | $4.5M | Buy |
+94,905
| New | +$4.5M | 0.04% | 471 |
|
|
2019
Q3 | – | Sell |
-102,063
| Closed | -$6.56M | – | 1139 |
|
|
2019
Q2 | $6.56M | Buy |
102,063
+95,907
| +1,558% | +$6.16M | 0.18% | 115 |
|
|
2019
Q1 | $500K | Buy |
+6,156
| New | +$500K | 0.02% | 670 |
|
|
2017
Q1 | – | Sell |
-83,336
| Closed | -$3.99M | – | 580 |
|
|
2016
Q4 | $3.99M | Buy |
+83,336
| New | +$3.99M | 0.09% | 293 |
|